Policy

BIO advocates for laws, funding and other governmental actions that ensure that biotechnology companies are able to focus on their research to drive the future of innovation.

Press Releases

BIO Statement on Veto of Prescription Drug Affordability Boards (PDAB) in Virginia

May 22, 2026

Patrick J. Plues, Senior Vice President of State Government Affairs & Affiliate Relations at the Biotechnology Innovation Organization (BIO) released the following statement on the veto of Prescription Drug Affordability Boards (PDAB) legislation in Virginia:“BIO applauds Governor Spanberger’s…

BIO Statement on Resignation of FDA Commissioner Marty Makary

May 12, 2026

WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the resignation of FDA Commissioner Marty Makary.“Dr. Makary inherited an FDA in crisis after the DOGE changes, which included the firing of thousands of…

BIO Launches “The Fight of Our Lives,” a National Campaign to Spotlight the Impact of Biotechnology on the Lives of Patients and Families

April 15, 2026

WASHINGTON, DC – Today, the Biotechnology Innovation Organization (BIO) announced the launch of The Fight of Our Lives, a new national campaign focused on the stories behind biotechnology breakthroughs, the patients whose lives depend on them, and the scientists working to make them possible…